Physician profile
Christopher T Behr
NPI 1295797793
$66,245.73
in general payments reported to CMS, 2019-2025
13 companies · $14K in 2025
The $14K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $586 · 2021: $3,611 · 2022: $26K · 2023: $1,833 · 2024: $20K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $26K · Consulting Fee: $8,186 · Grant: $1,370 · Food and Beverage: $724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $25,953.42 |
| Consulting Fee | $8,185.75 |
| Grant | $1,370.00 |
| Food and Beverage | $723.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $62,436.41 | 2019-2025 | Donjoy, Procare, Aircast |
| Impactortho, INC. | $1,845.40 | 2021-2022 | |
| Arthrex, INC. | $1,409.84 | 2019-2022 | |
| Linvatec Corporation | $219.36 | 2023-2024 | Biobrace 23mm |
| Stryker Corporation | $205.75 | 2022-2025 | Inspace, Triathlon |
| Microport Orthopedics INC | $18.84 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $17.67 | 2025 | |
| Wright Medical Technology, INC. | $17.24 | 2019 | |
| Heron Therapeutics, INC. | $17.19 | 2022 | |
| Elevate Surgical Co | $16.56 | 2023 | |
| Boston Scientific Corporation | $14.96 | 2024 | Wavewriter Alpha Prime 16 |
| Fidia Pharma USA INC. | $13.26 | 2023 | Hymovis, Triluron |
| Depuy Synthes Sales INC. | $13.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Behr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.